1M
MED icon

13D Management’s Medifast MED Stock Holding History

13D Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-57,533
Closed -$7.98M – 33
2020
Q2 		$7.98M Sell
57,533
-102,691
-64% -$9.43M 3.47% 15
2020
Q1 		$10M Buy
160,224
+9,734
+6% +$886K 4.87% 9
2019
Q4 		$16.5M Buy
+150,490
New +$14.6M 5.01% 3

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

13D Management's MED Position: Q3 2020 in Review

13D Management sold out of Medifast (MED) in Q3 2020, closing a stake of 57,533 shares — an estimated $7.98M sold.

13D Management first reported a position in MED in Q4 2019 and held it in 3 quarters. The position peaked at $16.5M in Q4 2019. 240 funds tracked by Wall St. Rank hold MED as of Q3 2020.

  • 13D Management reported no remaining Medifast position as of Q3 2020 after selling out during the quarter.
  • 13D Management sold 57,533 Medifast shares in Q3 2020, an estimated $7.98M.
  • 13D Management first reported a position in Medifast in Q4 2019 and held it in 3 quarters.
  • 13D Management's Medifast position peaked at $16.5M in Q4 2019.
  • 240 funds tracked by Wall St. Rank held Medifast as of Q3 2020.

Based on 13D Management's 13F filing for Q3 2020, filed 16 Nov 2020.